世界の人工血液市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Artificial Blood Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0447 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、人工血液のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト血液、合成血液、動物血液）、用途別市場規模（ヘモグロビンベース酸素運搬体（HBOC）、パーフルオロカーボンエマルジョン（PFCE））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・人工血液の市場動向 ・企業の競争状況、市場シェア ・人工血液の種類別市場規模（ヒト血液、合成血液、動物血液） ・人工血液の用途別市場規模（ヘモグロビンベース酸素運搬体（HBOC）、パーフルオロカーボンエマルジョン（PFCE）） ・人工血液の北米市場規模2016-2027（アメリカ、カナダ） ・人工血液のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・人工血液のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・人工血液の中南米市場規模2016-2027（メキシコ、ブラジル） ・人工血液の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dextro-Sang Corporation、BioPure Corporation、Sangart、Northfield Laboratories、Baxter International、Dentritech、FluorO2 Therapeutics、Nuvox Pharma、Alpha Therapeutic Corporation、HemoBioTech） ・結論

Artificial blood, also called oxygen therapeutics or hemoglobin-based oxygen carriers, offer the promise of new life-saving medical treatments.
Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body.

Market Analysis and Insights: Global Artificial Blood Market
The global Artificial Blood market size is projected to reach US$ 6067.5 million by 2026, from US$ 2786.6 million in 2019, at a CAGR of 11.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Blood market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Blood market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Blood market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Blood market.

Global Artificial Blood Scope and Market Size
Artificial Blood market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Blood market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Human Blood
Synthetic Blood
Animal Blood

Segment by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Blood Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human Blood
1.2.3 Synthetic Blood
1.2.4 Animal Blood
1.3 Market by Application
1.3.1 Global Artificial Blood Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
1.3.3 Perflurocarbon Emulsions (PFCEs)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Artificial Blood Market Perspective (2016-2027)
2.2 Artificial Blood Growth Trends by Regions
2.2.1 Artificial Blood Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Artificial Blood Historic Market Share by Regions (2016-2021)
2.2.3 Artificial Blood Forecasted Market Size by Regions (2022-2027)
2.3 Artificial Blood Industry Dynamic
2.3.1 Artificial Blood Market Trends
2.3.2 Artificial Blood Market Drivers
2.3.3 Artificial Blood Market Challenges
2.3.4 Artificial Blood Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Artificial Blood Players by Revenue
3.1.1 Global Top Artificial Blood Players by Revenue (2016-2021)
3.1.2 Global Artificial Blood Revenue Market Share by Players (2016-2021)
3.2 Global Artificial Blood Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Artificial Blood Revenue
3.4 Global Artificial Blood Market Concentration Ratio
3.4.1 Global Artificial Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Revenue in 2020
3.5 Artificial Blood Key Players Head office and Area Served
3.6 Key Players Artificial Blood Product Solution and Service
3.7 Date of Enter into Artificial Blood Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Blood Breakdown Data by Type
4.1 Global Artificial Blood Historic Market Size by Type (2016-2021)
4.2 Global Artificial Blood Forecasted Market Size by Type (2022-2027)

5 Artificial Blood Breakdown Data by Application
5.1 Global Artificial Blood Historic Market Size by Application (2016-2021)
5.2 Global Artificial Blood Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Artificial Blood Market Size (2016-2027)
6.2 North America Artificial Blood Market Size by Type
6.2.1 North America Artificial Blood Market Size by Type (2016-2021)
6.2.2 North America Artificial Blood Market Size by Type (2022-2027)
6.2.3 North America Artificial Blood Market Size by Type (2016-2027)
6.3 North America Artificial Blood Market Size by Application
6.3.1 North America Artificial Blood Market Size by Application (2016-2021)
6.3.2 North America Artificial Blood Market Size by Application (2022-2027)
6.3.3 North America Artificial Blood Market Size by Application (2016-2027)
6.4 North America Artificial Blood Market Size by Country
6.4.1 North America Artificial Blood Market Size by Country (2016-2021)
6.4.2 North America Artificial Blood Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Artificial Blood Market Size (2016-2027)
7.2 Europe Artificial Blood Market Size by Type
7.2.1 Europe Artificial Blood Market Size by Type (2016-2021)
7.2.2 Europe Artificial Blood Market Size by Type (2022-2027)
7.2.3 Europe Artificial Blood Market Size by Type (2016-2027)
7.3 Europe Artificial Blood Market Size by Application
7.3.1 Europe Artificial Blood Market Size by Application (2016-2021)
7.3.2 Europe Artificial Blood Market Size by Application (2022-2027)
7.3.3 Europe Artificial Blood Market Size by Application (2016-2027)
7.4 Europe Artificial Blood Market Size by Country
7.4.1 Europe Artificial Blood Market Size by Country (2016-2021)
7.4.2 Europe Artificial Blood Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Artificial Blood Market Size (2016-2027)
8.2 Asia-Pacific Artificial Blood Market Size by Type
8.2.1 Asia-Pacific Artificial Blood Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Artificial Blood Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Artificial Blood Market Size by Type (2016-2027)
8.3 Asia-Pacific Artificial Blood Market Size by Application
8.3.1 Asia-Pacific Artificial Blood Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Artificial Blood Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Artificial Blood Market Size by Application (2016-2027)
8.4 Asia-Pacific Artificial Blood Market Size by Region
8.4.1 Asia-Pacific Artificial Blood Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Artificial Blood Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Artificial Blood Market Size (2016-2027)
9.2 Latin America Artificial Blood Market Size by Type
9.2.1 Latin America Artificial Blood Market Size by Type (2016-2021)
9.2.2 Latin America Artificial Blood Market Size by Type (2022-2027)
9.2.3 Latin America Artificial Blood Market Size by Type (2016-2027)
9.3 Latin America Artificial Blood Market Size by Application
9.3.1 Latin America Artificial Blood Market Size by Application (2016-2021)
9.3.2 Latin America Artificial Blood Market Size by Application (2022-2027)
9.3.3 Latin America Artificial Blood Market Size by Application (2016-2027)
9.4 Latin America Artificial Blood Market Size by Country
9.4.1 Latin America Artificial Blood Market Size by Country (2016-2021)
9.4.2 Latin America Artificial Blood Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Artificial Blood Market Size (2016-2027)
10.2 Middle East & Africa Artificial Blood Market Size by Type
10.2.1 Middle East & Africa Artificial Blood Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Artificial Blood Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Artificial Blood Market Size by Type (2016-2027)
10.3 Middle East & Africa Artificial Blood Market Size by Application
10.3.1 Middle East & Africa Artificial Blood Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Artificial Blood Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Artificial Blood Market Size by Application (2016-2027)
10.4 Middle East & Africa Artificial Blood Market Size by Country
10.4.1 Middle East & Africa Artificial Blood Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Artificial Blood Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dextro-Sang Corporation
11.1.1 Dextro-Sang Corporation Company Details
11.1.2 Dextro-Sang Corporation Business Overview
11.1.3 Dextro-Sang Corporation Artificial Blood Introduction
11.1.4 Dextro-Sang Corporation Revenue in Artificial Blood Business (2016-2021)
11.1.5 Dextro-Sang Corporation Recent Development
11.2 BioPure Corporation
11.2.1 BioPure Corporation Company Details
11.2.2 BioPure Corporation Business Overview
11.2.3 BioPure Corporation Artificial Blood Introduction
11.2.4 BioPure Corporation Revenue in Artificial Blood Business (2016-2021)
11.2.5 BioPure Corporation Recent Development
11.3 Sangart
11.3.1 Sangart Company Details
11.3.2 Sangart Business Overview
11.3.3 Sangart Artificial Blood Introduction
11.3.4 Sangart Revenue in Artificial Blood Business (2016-2021)
11.3.5 Sangart Recent Development
11.4 Northfield Laboratories
11.4.1 Northfield Laboratories Company Details
11.4.2 Northfield Laboratories Business Overview
11.4.3 Northfield Laboratories Artificial Blood Introduction
11.4.4 Northfield Laboratories Revenue in Artificial Blood Business (2016-2021)
11.4.5 Northfield Laboratories Recent Development
11.5 Baxter International
11.5.1 Baxter International Company Details
11.5.2 Baxter International Business Overview
11.5.3 Baxter International Artificial Blood Introduction
11.5.4 Baxter International Revenue in Artificial Blood Business (2016-2021)
11.5.5 Baxter International Recent Development
11.6 Dentritech
11.6.1 Dentritech Company Details
11.6.2 Dentritech Business Overview
11.6.3 Dentritech Artificial Blood Introduction
11.6.4 Dentritech Revenue in Artificial Blood Business (2016-2021)
11.6.5 Dentritech Recent Development
11.7 FluorO2 Therapeutics
11.7.1 FluorO2 Therapeutics Company Details
11.7.2 FluorO2 Therapeutics Business Overview
11.7.3 FluorO2 Therapeutics Artificial Blood Introduction
11.7.4 FluorO2 Therapeutics Revenue in Artificial Blood Business (2016-2021)
11.7.5 FluorO2 Therapeutics Recent Development
11.8 Nuvox Pharma
11.8.1 Nuvox Pharma Company Details
11.8.2 Nuvox Pharma Business Overview
11.8.3 Nuvox Pharma Artificial Blood Introduction
11.8.4 Nuvox Pharma Revenue in Artificial Blood Business (2016-2021)
11.8.5 Nuvox Pharma Recent Development
11.9 Alpha Therapeutic Corporation
11.9.1 Alpha Therapeutic Corporation Company Details
11.9.2 Alpha Therapeutic Corporation Business Overview
11.9.3 Alpha Therapeutic Corporation Artificial Blood Introduction
11.9.4 Alpha Therapeutic Corporation Revenue in Artificial Blood Business (2016-2021)
11.9.5 Alpha Therapeutic Corporation Recent Development
11.10 HemoBioTech
11.10.1 HemoBioTech Company Details
11.10.2 HemoBioTech Business Overview
11.10.3 HemoBioTech Artificial Blood Introduction
11.10.4 HemoBioTech Revenue in Artificial Blood Business (2016-2021)
11.10.5 HemoBioTech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Artificial Blood Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human Blood
Table 3. Key Players of Synthetic Blood
Table 4. Key Players of Animal Blood
Table 5. Global Artificial Blood Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Artificial Blood Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Artificial Blood Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Artificial Blood Market Share by Regions (2016-2021)
Table 9. Global Artificial Blood Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Artificial Blood Market Share by Regions (2022-2027)
Table 11. Artificial Blood Market Trends
Table 12. Artificial Blood Market Drivers
Table 13. Artificial Blood Market Challenges
Table 14. Artificial Blood Market Restraints
Table 15. Global Artificial Blood Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Artificial Blood Market Share by Players (2016-2021)
Table 17. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Blood as of 2020)
Table 18. Ranking of Global Top Artificial Blood Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Artificial Blood Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Artificial Blood Product Solution and Service
Table 22. Date of Enter into Artificial Blood Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Artificial Blood Revenue Market Share by Type (2016-2021)
Table 26. Global Artificial Blood Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Artificial Blood Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Artificial Blood Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Artificial Blood Revenue Market Share by Application (2016-2021)
Table 30. Global Artificial Blood Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Artificial Blood Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Artificial Blood Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Artificial Blood Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Artificial Blood Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Artificial Blood Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Artificial Blood Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Artificial Blood Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Artificial Blood Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Artificial Blood Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Artificial Blood Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Artificial Blood Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Artificial Blood Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Artificial Blood Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Artificial Blood Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Artificial Blood Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Artificial Blood Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Artificial Blood Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Artificial Blood Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Artificial Blood Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Artificial Blood Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Artificial Blood Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Artificial Blood Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Artificial Blood Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Artificial Blood Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Artificial Blood Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Artificial Blood Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Artificial Blood Market Size by Country (2022-2027) & (US$ Million)
Table 62. Dextro-Sang Corporation Company Details
Table 63. Dextro-Sang Corporation Business Overview
Table 64. Dextro-Sang Corporation Artificial Blood Product
Table 65. Dextro-Sang Corporation Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 66. Dextro-Sang Corporation Recent Development
Table 67. BioPure Corporation Company Details
Table 68. BioPure Corporation Business Overview
Table 69. BioPure Corporation Artificial Blood Product
Table 70. BioPure Corporation Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 71. BioPure Corporation Recent Development
Table 72. Sangart Company Details
Table 73. Sangart Business Overview
Table 74. Sangart Artificial Blood Product
Table 75. Sangart Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 76. Sangart Recent Development
Table 77. Northfield Laboratories Company Details
Table 78. Northfield Laboratories Business Overview
Table 79. Northfield Laboratories Artificial Blood Product
Table 80. Northfield Laboratories Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 81. Northfield Laboratories Recent Development
Table 82. Baxter International Company Details
Table 83. Baxter International Business Overview
Table 84. Baxter International Artificial Blood Product
Table 85. Baxter International Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 86. Baxter International Recent Development
Table 87. Dentritech Company Details
Table 88. Dentritech Business Overview
Table 89. Dentritech Artificial Blood Product
Table 90. Dentritech Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 91. Dentritech Recent Development
Table 92. FluorO2 Therapeutics Company Details
Table 93. FluorO2 Therapeutics Business Overview
Table 94. FluorO2 Therapeutics Artificial Blood Product
Table 95. FluorO2 Therapeutics Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 96. FluorO2 Therapeutics Recent Development
Table 97. Nuvox Pharma Company Details
Table 98. Nuvox Pharma Business Overview
Table 99. Nuvox Pharma Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 100. Nuvox Pharma Recent Development
Table 101. Alpha Therapeutic Corporation Company Details
Table 102. Alpha Therapeutic Corporation Business Overview
Table 103. Alpha Therapeutic Corporation Artificial Blood Product
Table 104. Alpha Therapeutic Corporation Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 105. Alpha Therapeutic Corporation Recent Development
Table 106. HemoBioTech Company Details
Table 107. HemoBioTech Business Overview
Table 108. HemoBioTech Artificial Blood Product
Table 109. HemoBioTech Revenue in Artificial Blood Business (2016-2021) & (US$ Million)
Table 110. HemoBioTech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Blood Market Share by Type: 2020 VS 2027
Figure 2. Human Blood Features
Figure 3. Synthetic Blood Features
Figure 4. Animal Blood Features
Figure 5. Global Artificial Blood Market Share by Application: 2020 VS 2027
Figure 6. Hemoglobin-Based Oxygen Carriers (HBOCs) Case Studies
Figure 7. Perflurocarbon Emulsions (PFCEs) Case Studies
Figure 8. Artificial Blood Report Years Considered
Figure 9. Global Artificial Blood Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Artificial Blood Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Artificial Blood Market Share by Regions: 2020 VS 2027
Figure 12. Global Artificial Blood Market Share by Regions (2022-2027)
Figure 13. Global Artificial Blood Market Share by Players in 2020
Figure 14. Global Top Artificial Blood Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Blood as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Artificial Blood Revenue in 2020
Figure 16. Global Artificial Blood Revenue Market Share by Type (2016-2021)
Figure 17. Global Artificial Blood Revenue Market Share by Type (2022-2027)
Figure 18. North America Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Artificial Blood Market Share by Type (2016-2027)
Figure 20. North America Artificial Blood Market Share by Application (2016-2027)
Figure 21. North America Artificial Blood Market Share by Country (2016-2027)
Figure 22. United States Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Artificial Blood Market Share by Type (2016-2027)
Figure 26. Europe Artificial Blood Market Share by Application (2016-2027)
Figure 27. Europe Artificial Blood Market Share by Country (2016-2027)
Figure 28. Germany Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Artificial Blood Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Artificial Blood Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Artificial Blood Market Share by Region (2016-2027)
Figure 38. China Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Artificial Blood Market Share by Type (2016-2027)
Figure 46. Latin America Artificial Blood Market Share by Application (2016-2027)
Figure 47. Latin America Artificial Blood Market Share by Country (2016-2027)
Figure 48. Mexico Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Artificial Blood Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Artificial Blood Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Artificial Blood Market Share by Country (2016-2027)
Figure 54. Turkey Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Artificial Blood Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Dextro-Sang Corporation Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 58. BioPure Corporation Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 59. Sangart Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 60. Northfield Laboratories Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 61. Baxter International Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 62. Dentritech Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 63. FluorO2 Therapeutics Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 64. Nuvox Pharma Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 65. Alpha Therapeutic Corporation Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 66. HemoBioTech Revenue Growth Rate in Artificial Blood Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---